Amneal Reports Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Amneal Pharmaceuticals (AMRX) Tops Q2 EPS by 6c
August 9, 2021 6:03 AM EDTAmneal Pharmaceuticals (: AMRX) reported Q2 EPS of $0.25, $0.06 better than the analyst estimate of $0.19. Revenue for the quarter came in at $535 million versus the consensus estimate of $523.25 million.
GUIDANCE:
Amneal Pharmaceuticals sees FY2021 EPS of $0.70-$0.85, versus the consensus of $0.82. Amneal... More
